Hybrid Argon Plasma Coagulation (HybridAPC) versus resection in the surgical treatment of peritoneal endometriosis

Not Applicable

• Conditions: N80; Endometriosis

• Registration Number: DRKS00011313
• Lead Sponsor: Forschungsinstitut für FrauengesundheitDepartment für Frauengesundheit

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-04-26
• Study Completion: 2018-03-22
• Results First Posted: 2022-03-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 48

Inclusion Criteria

all patients with peritoneal endometriotic lesions can be included, with no second laryoscopy (group A) and patients who need second laryoscopy to restore the TIE (group B).

Exclusion Criteria

- Age under 18 years
- non-compliant patients
- pregnant patients
- patients with peritoneal endometriotic origin exclusively in the area of ??the ureter and close to the intestine
- lack of patient consent

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary target criterion is the histological eradication rate of the treated endometrium at the time of the second laparoscopy (approximately four to eight weeks after intervention)

Secondary Outcome Measures

Name	Time	Method
- Investigation of the adhesion formation at the time of second laryoscopy (frequency of adhesion and adhesion quality)<br>- Comparison of the duration of intervention per endometriosis lesions with different resection methods<br>- size of the wound surface immediately after treatment in the first laparoscopy